HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 263 filers reported holding HAEMONETICS CORP in Q1 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,019 | +5.2% | 123 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $10,473 | -5.6% | 123 | -8.2% | 0.00% | 0.0% |
| Q1 2023 | $11,089 | -46.0% | 134 | -48.7% | 0.00% | -50.0% |
| Q4 2022 | $20,528 | +105.3% | 261 | +94.8% | 0.00% | +100.0% |
| Q3 2022 | $10,000 | +11.1% | 134 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $9,000 | +28.6% | 134 | +27.6% | 0.00% | 0.0% |
| Q1 2022 | $7,000 | +133.3% | 105 | +64.1% | 0.00% | – |
| Q4 2021 | $3,000 | -66.7% | 64 | -48.0% | 0.00% | -100.0% |
| Q3 2021 | $9,000 | +50.0% | 123 | +46.4% | 0.00% | 0.0% |
| Q2 2021 | $6,000 | 0.0% | 84 | +55.6% | 0.00% | 0.0% |
| Q1 2021 | $6,000 | +20.0% | 54 | +28.6% | 0.00% | 0.0% |
| Q4 2020 | $5,000 | +25.0% | 42 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $4,000 | -42.9% | 42 | -47.5% | 0.00% | -50.0% |
| Q2 2020 | $7,000 | -85.7% | 80 | -83.6% | 0.00% | -75.0% |
| Q1 2020 | $49,000 | -3.9% | 488 | +5.9% | 0.01% | +33.3% |
| Q4 2019 | $51,000 | -10.5% | 461 | 0.0% | 0.01% | -33.3% |
| Q3 2019 | $57,000 | +5.6% | 461 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $54,000 | 0.0% | 461 | -28.7% | 0.01% | 0.0% |
| Q1 2019 | $54,000 | +671.4% | 647 | +708.8% | 0.01% | +350.0% |
| Q4 2018 | $7,000 | -12.5% | 80 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $8,000 | +33.3% | 80 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $6,000 | +20.0% | 80 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $5,000 | +25.0% | 80 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $4,000 | +100.0% | 80 | 0.0% | 0.00% | +100.0% |
| Q3 2017 | $2,000 | – | 80 | +110.5% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 38 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 38 | 0.0% | 0.00% | -100.0% |
| Q4 2016 | $1,000 | -50.0% | 38 | -56.8% | 0.00% | 0.0% |
| Q3 2016 | $2,000 | +100.0% | 88 | +131.6% | 0.00% | 0.0% |
| Q2 2016 | $1,000 | 0.0% | 38 | -9.5% | 0.00% | 0.0% |
| Q1 2016 | $1,000 | – | 42 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |